Spots Global Cancer Trial Database for bladder neoplasms
Every month we try and update this database with for bladder neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer | NCT06310759 | Urothelial Carc... | 18 Years - 100 Years | Tampere University Hospital | ||
| Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ | NCT00462488 | Urinary Bladder... Bladder Cancer Bladder Neoplas... Bladder Tumors | Vicinium | 18 Years - | Sesen Bio, Inc. | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium | NCT00077688 | Bladder Neoplas... Ureteral Neopla... Urethral Neopla... Carcinoma, Tran... | TOCOSOL Paclita... | 18 Years - | Achieve Life Sciences | |
| Bladder Cancer Patient-Reported Outcomes | NCT01090388 | Bladder Neoplas... | 18 Years - | Baylor College of Medicine | ||
| Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer | NCT00583349 | Bladder Cancer | Paclitaxel, nan... | 18 Years - | Columbia University | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract | NCT00315237 | Transitional Ce... Bladder Cancer Bladder Neoplas... | vinflunine and ... | 18 Years - | Bristol-Myers Squibb | |
| Molecular Analysis Of Bladder Cancer | NCT00871754 | Bladder Cancer Bladder Neoplas... | 18 Years - | Lahey Clinic | ||
| Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | NCT00101608 | Transitional Ce... Bladder Neoplas... Kidney Neoplasm... Ureter Neoplasm... Bladder Cancer Neoplasm, Bladd... | vinflunine | 18 Years - | Bristol-Myers Squibb | |
| Image-Guided Tumorboost of Bladder Cancer | NCT00963404 | Bladder Neoplas... | Radiation boost | 18 Years - | University of Aarhus | |
| A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer | NCT05699135 | Urinary Bladder... Bladder Cancer Bladder Tumors Urothelial Carc... | Avelumab first-... | 18 Years - | Pfizer | |
| Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer | NCT00583349 | Bladder Cancer | Paclitaxel, nan... | 18 Years - | Columbia University | |
| Phase II Trial of EOquin in High-risk Superficial Bladder Cancer | NCT00141531 | Bladder Neoplas... | Apaziquone | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Image-Guided Tumorboost of Bladder Cancer | NCT00963404 | Bladder Neoplas... | Radiation boost | 18 Years - | University of Aarhus | |
| Instillation of Gemcitabine in Patients With Superficial Bladder Cancer | NCT00191477 | Bladder Neoplas... | Gemcitabine Placebo | 18 Years - | Eli Lilly and Company | |
| A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer | NCT05699135 | Urinary Bladder... Bladder Cancer Bladder Tumors Urothelial Carc... | Avelumab first-... | 18 Years - | Pfizer | |
| Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract | NCT00315237 | Transitional Ce... Bladder Cancer Bladder Neoplas... | vinflunine and ... | 18 Years - | Bristol-Myers Squibb | |
| Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer | NCT00393809 | Bladder Neoplas... | DTA-H19 | 18 Years - | Hebrew University of Jerusalem | |
| A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816) | NCT00536588 | Bladder Neoplas... | SCH 721015 with... | 18 Years - | Merck Sharp & Dohme LLC | |
| Image-Guided Tumorboost of Bladder Cancer | NCT00963404 | Bladder Neoplas... | Radiation boost | 18 Years - | University of Aarhus | |
| Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer | NCT05072600 | Bladder Cancer Bladder Neoplas... Bladder Tumors Urinary Bladder... Neoplasms, Blad... | Pembrolizumab | 18 Years - | Peking University First Hospital | |
| Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder | NCT00343356 | Bladder Neoplas... | Trement | 26 Years - 72 Years | LanZhou University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
